Skip to main content

Collaborative study uncovers unknown causes of blindness

January 22, 2026

News from outside our WAEH Network

Researchers from Radboud university medical center and Institute of Molecular and Clinical Ophthalmology Basel have discovered new genetic causes of inherited blindness. Their study shows that changes in specific pieces of DNA, which play a role in processing genetic information, can lead to retinitis pigmentosa. This eye condition affects about 1 in 5,000 people worldwide, causing ‘tunnel vision’ and often leads to legal blindness. The discovery provides clarity for dozens of families globally and opens new possibilities for diagnostics and counseling in hereditary conditions.

Retinitis pigmentosa (RP) is a disorder in which the rod cells and later also the cone cells in the retina gradually die. Affected individuals first experience night blindness, followed by tunnel vision. Some eventually lose their sight completely. Although more than a hundred genes are known to cause RP, in 30 to 50 percent of patients the genetic cause remains unresolved, even after extensive DNA testing. Researchers at Radboudumc have now solved part of this puzzle.

From one family to dozens

The discovery began with an American family of a father and eight children affected by blindness and other genetic conditions. ‘They came to us asking: what’s behind this? Is there one cause explaining all these conditions, or are multiple genes involved?’ says lead researcher Susanne Roosing, molecular geneticist at Radboudumc. ‘We did not find a cause in a known RP gene. So, we analyzed the entire DNA of the parents and children. That explained the other conditions, but not the RP. We knew then we had to look for a new cause. A huge challenge, but eventually we found a variation in the gene RNU4-2.’

The change occurs in a special gene, RNU4-2, which does not produce a protein but only RNA. RNA from such genes associate with proteins and other RNAs and the whole resulting complex assists in editing genetic information (splicing), a step required before a cell can make proteins. Other changes in RNU4-2 were recently linked to developmental disorders. The variant in the American family with RP, however, sits at a critical hinge point in the RNA. This disrupts a regulatory mechanism which apparently important for the retina, ultimately leading to blindness.

Analysis of 5,000 patients

Together with researchers Mathieu Quinodoz and Carlo Rivolta from the Institute of Molecular and Clinical Ophthalmology Basel / the University of Basel and colleagues worldwide, the team launched a large-scale analysis of DNA from 5,000 patients whose genetic cause underlying RP was still unknown. They found, in addition to changes in RNU4-2, four similar genes, providing a molecular diagnosis for 153 individuals from 67 families. These variants now explain about 1.4 percent of all unresolved RP cases worldwide. ‘This is a huge step forward’, says Kim Rodenburg, genetic researcher at Radboudumc. ‘We’ve not only identified a new cause of blindness, but we also show that DNA segments that don’t make proteins are still crucial. Non-coding genes have never been linked to inherited retinal diseases.’

The American family that started this search is thrilled with the breakthrough. They never expected that research into their genes would help 66 other families. ‘They now know the source of their blindness,’ Roosing explains. ‘And they can make informed choices, such as using preimplantation genetic testing to prevent passing the condition to their children. That’s incredibly valuable.’

A new chapter in genetics

This breakthrough goes beyond these specific genetic variants causing RP. It shows that we should also look beyond protein-coding genes.’ Rodenburg: ‘We’ve learned that changes in these RNA genes can be just as impactful as changes in protein-coding genes. This is fundamental knowledge that broadens our understanding of hereditary diseases.’

About this publication

This article was published in Nature Genetics: De novo and inherited dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa – Mathieu Quinodoz, Kim Rodenburg, Zuzana Cvackova, Karolina Kaminska, Suzanne E. de Bruijn […], Frans P. M. Cremers, Winston Lee, Jamie M. Ellingford, David Stanek, Susanne Roosing#, Carlo Rivolta#. DOI: 10.1038/s41588-025-02451-4.

Date: January 9, 2026
Source: Radboudumc

Older news


More recent

WAEH welcomes its 2026 Project Cohort

The World Association of Eye Hospitals (WAEH) is proud to welcome a new cohort of international projects that will contribute to improving eye care around the world through collaboration, innovation and shared expertise. Official Kick-off on 31 August The WAEH Project Kick-off 2026 will take place on Monday, 31 August 2026, at 13:00 CEST. During […]

WAEH invited to contribute to IAPB policy roundtables in Brussels

The World Association of Eye Hospitals (WAEH) has been invited by the International Agency for the Prevention of Blindness (IAPB) to participate in two high-level policy roundtables in Brussels on 15 and 16 July. The discussions will explore the role of eye health in education, healthy ageing and workforce participation, while helping to shape Europe’s […]

Newsletter WAEH | June 2026

Join the WAEH 20th Annual Meeting! Source: Adobe stock 🎉Our 20th Annual Meeting is coming up, and this year we are celebrating our Jubileum Year! This year the meeting will be in São Paulo (Brazil) from 9 – 13 November to share best practices in eye hospitals worldwide. There will also be facultative visits to […]

Flying Eye & ENT Hospital completes two international missions in 2026

News from our full member Eye & ENT Hospital of Fudan University (Shanghai, China) The Flying Eye & ENT Hospital of Fudan University has successfully completed two international outreach missions in 2026, further strengthening its commitment to improving access to specialized eye and ENT care worldwide. The first mission took place in Laos in February 2026, followed […]

WAEH at Londrina Unity Health

The World Association of Eye Hospitals (WAEH) has been invited to contribute to Londrina Unity Health 2026, one of the largest private healthcare management conferences in Southern Brazil, taking place on 13–14 August 2026 in Londrina, Brazil. Our Global Lead, Maaike van Zuilen, will deliver a presentation on the WAEH, highlighting how international collaboration between eye hospitals helps accelerate innovation, […]